Dixon Hughes Goodman Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3K	Buy	176 +87	+98%	+$1.28K	﹤0.01%	693
2021 Q4	$1K	Buy	+89	New	+$1.25K	﹤0.01%	786

Other funds holding TAK

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's TAK Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors increased its Takeda Pharmaceutical (TAK) stake by 98% in Q1 2022, buying an estimated $1.28K and bringing the position to 176 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Dixon Hughes Goodman Wealth Advisors first reported a position in TAK in Q4 2021 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 176 shares of Takeda Pharmaceutical worth $3K as of Q1 2022.
Dixon Hughes Goodman Wealth Advisors bought 87 Takeda Pharmaceutical shares in Q1 2022, an estimated $1.28K.
Takeda Pharmaceutical made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #693 holding.
Dixon Hughes Goodman Wealth Advisors first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 2 quarters since.
287 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.